BMS halts hep C candidate development after patient death
Promises to share drug data to assist other pharma companies’ patient safety measures
Read More
Section: Research
Bayer launches late-stage lung condition trial for ciprofloxacin
Study involves the use of Novartis’ T-326 inhaler
Read More
Orphan drugs economically viable for pharma
Drugs for rare diseases can generate as much lifetime revenue as medicines for common conditions
Read More
New malaria reference lab to help move vaccine candidates into trials
PATH Malaria Vaccine Initiative collaborates with the International AIDS Vaccine Initiative and Imperial College London
Read More
Driving early clinical and commercial alignment
Real-world studies can provide evidence to ensure that your brand resonates with your customers
Read More